Genetic counseling is a health service that helps people understand how inherited genetic changes may affect their health or their relatives’ health. It transforms inherited risk from a confusing family-history concern into a more individualized, evidence-based discussion: a counselor can review family patterns, explain testing options and limits, interpret results, and help people consider next steps without making decisions for them. The need is substantial: the U.S. Centers for Disease Control and Prevention (CDC) estimates that at least 1 in 10 people has a family history that increases their risk of a common chronic disease, while the National Cancer Institute notes that inherited variants account for roughly 5% to 10% of all cancers. Counseling helps put such figures in context by distinguishing population statistics from a person’s own likelihood and by connecting risk assessment with genetic testing, prevention, and family communication.
Genetic counseling clarifies inherited risk
The National Society of Genetic Counselors (NSGC) describes genetic counseling as a process that helps people understand and adapt to the medical, psychological, and familial implications of genetic contributions to disease. In practice, it is a conversation and clinical service—not simply a blood test or a prediction. A genetic counselor gathers relevant personal and family medical information, explains inheritance and uncertainty, and supports informed choices based on a person’s circumstances and values.
Inherited risk is not the same as certainty. A pathogenic variant may substantially raise the chance of a condition without guaranteeing it will occur; conversely, a negative test may not erase risk arising from family history, other genes, or environmental and lifestyle factors. Counseling makes these distinctions explicit, helping people move from “it runs in my family” to a clearer account of what is known, what remains uncertain, and what actions may be appropriate.
Family history as a starting point
A pedigree is a structured record of health conditions and relationships across generations. Counselors may ask about diagnoses, ages at diagnosis, ancestry, and relevant reproductive or medical history. Patterns such as several close relatives with the same cancer, unusually young diagnoses, or a condition appearing in successive generations can suggest an inherited predisposition. These clues guide risk assessment, but they do not establish a diagnosis on their own.
The CDC’s estimate that at least 1 in 10 people has a family history associated with increased risk for common chronic disease underscores why family history matters. It is also an imperfect record: relatives may not know their diagnoses, family structures may limit available information, and small families can obscure patterns. A counselor can explain how these gaps affect the assessment rather than treating incomplete information as proof of low risk.
Risk is probabilistic, not a prediction
Genetic risk describes a change in probability, not a guaranteed future. The effect of a variant depends on the condition, the specific variant, family history, and sometimes factors such as age, sex, screening history, and exposures. For example, an inherited cancer-risk variant may lead to earlier or more frequent screening discussions, but it does not mean that cancer is inevitable. Counseling helps translate relative and lifetime risk estimates into practical meaning and identifies when estimates have important limitations.
This probabilistic approach also prevents two common misunderstandings: assuming that a concerning family history proves a genetic condition, or assuming that absence of a known variant means no risk. A person’s risk can remain elevated because testing has not identified the relevant cause, because the family pattern reflects multiple interacting factors, or because current science cannot yet explain it.
Genetic counseling guides testing and interpretation
After reviewing the history, a counselor can discuss whether genetic testing is useful, which test may fit the question, and what different results could mean. The U.S. National Library of Medicine’s MedlinePlus explains that genetic testing can help confirm or rule out a suspected genetic condition, identify a predisposition, or inform reproductive decisions. Testing is not automatically the best choice for every person: its value depends on whether results could clarify care, provide useful information to relatives, or answer a question the person wants addressed.
Choosing an appropriate test
Test options range from analysis of one gene to panels that examine many genes, and in some settings to broader genomic testing. The appropriate scope depends on the suspected condition, the family pattern, and the clinical question. A counselor can explain possible benefits and drawbacks, including the chance of uncertain findings, the possibility of incidental information, cost and coverage considerations, and the limits of what a particular test can detect.
When possible, testing a relative who has had the relevant condition can make a family’s results easier to interpret. If a disease-associated variant is found in that person, other relatives can be offered targeted testing for that specific variant. If no familial variant is identified, a negative result may be less informative because there is no known change against which to test. This distinction is central to understanding why “negative” does not always mean “average risk.”
Understanding positive, negative, and uncertain results
A positive result may identify a pathogenic or likely pathogenic variant associated with increased risk or a diagnosed condition. Its implications vary: it may prompt a discussion about screening, risk reduction, treatment choices, or testing relatives. A negative result means the test did not find the genetic change it was designed to identify; its meaning depends on whether a known familial variant was present and on the test’s scope.
A variant of uncertain significance (VUS) is a genetic change for which available evidence is insufficient to determine whether it affects health. The American College of Medical Genetics and Genomics (ACMG) recommends that a VUS should not be used to make clinical decisions. Counselors explain that evidence can change over time and that a VUS is not the same as a confirmed disease-causing result. This protects people from treating uncertainty as a diagnosis while keeping appropriate follow-up in view.
Putting results into a care plan
Interpretation connects laboratory findings to medical care. Depending on the result and personal history, a care plan may include routine screening, earlier or more frequent screening, referral to a specialist, preventive options, or no change to care at that time. The National Cancer Institute emphasizes that inherited cancer-risk results can inform prevention and screening decisions, but recommendations depend on the gene, the individual, and current clinical guidance.
Counseling also helps people weigh benefits and burdens rather than treating every possible intervention as mandatory. A result can raise emotional, practical, and ethical questions, including privacy concerns, family dynamics, and how much information a person wants. The counselor’s role is to support informed decision-making and coordinate with other clinicians when appropriate—not to prescribe a single personal choice.
Genetic counseling extends risk information to families
Genetic information can have implications beyond the person tested because close biological relatives may share a variant. Counseling helps clarify who might benefit from learning about a result, what information can be shared, and how to communicate it in a respectful, understandable way. The tested person generally decides whether and how to share personal information, while clinicians can help prepare family letters or explain the medical meaning of a result.
Cascade testing and relatives’ choices
Cascade testing is the process of offering targeted testing to relatives after a disease-associated variant is identified in a family. It can help relatives clarify their own risk and consider appropriate care. Each relative makes an independent decision about testing, and a counselor can explain the potential value, limitations, and implications before that decision is made.
For example, if a person with a strong family history of breast and ovarian cancer is found to carry a pathogenic variant in a relevant gene, adult relatives may be offered counseling about whether targeted testing is appropriate. A relative who does not carry the known familial variant may avoid certain variant-specific interventions, though their personal and family history still matters. A relative who does carry it can discuss individualized screening and risk-management options with their care team. This illustrates how counseling turns one result into a structured, family-aware process rather than a blanket prediction.
Reproductive and life-stage considerations
Some counseling addresses reproductive questions, including the chance of passing on a condition, carrier screening, prenatal testing, or preimplantation genetic testing. Other conversations occur at different life stages, such as when a child is being evaluated for a suspected inherited condition or when an adult considers testing for a condition that may develop later. The purpose is to explain available information and options in a non-directive manner, recognizing that personal beliefs and preferences shape decisions.
The CDC notes that family health history can help clinicians identify people who may benefit from earlier or more frequent screening and other preventive steps. Genetic counseling adds another layer by clarifying whether a suspected inherited cause can be investigated and how results may matter to relatives. It does not replace routine preventive care or guarantee that every inherited condition can be detected.
Access, limitations, and responsible use of counseling
Genetic counseling is increasingly available through clinics, telehealth, and some testing services, but access, cost, insurance coverage, and availability vary. A person may be referred by a primary-care clinician or specialist, or may seek a counselor through a professional directory. For complex medical questions, counseling connected with qualified health-care professionals can help ensure that testing and interpretation are considered alongside the full clinical picture.
Direct-to-consumer testing has limits
Direct-to-consumer genetic tests may provide information about selected traits or health risks, but they do not necessarily examine all clinically relevant variants or provide a complete assessment. The U.S. Food and Drug Administration (FDA) cautions that a consumer test result should not be the sole basis for medical decisions. A health-related finding should be discussed with a qualified clinician, and confirmatory testing in a clinical setting may be appropriate before changing care.
Counseling can help distinguish an ancestry or wellness report from a clinically actionable result. It can also clarify that a test’s “low-risk” result does not rule out disease, particularly when a strong family history is present. The key question is not simply whether a test produces information, but whether the information is valid for the intended purpose and useful for the person’s decisions.
Privacy, uncertainty, and emotional support
Genetic information can feel personal because it may reveal implications for health, relatives, and future plans. Counseling provides space to discuss confidentiality, possible insurance or employment concerns, emotional responses, and the limits of legal protections. In the United States, the Genetic Information Nondiscrimination Act (GINA) generally restricts the use of genetic information by health insurers and employers, but it does not cover every type of insurance, including life, disability, and long-term-care insurance. People should seek current, jurisdiction-specific guidance before testing if these issues are important to them.
Uncertainty is a normal part of genetics. A result may be inconclusive, scientific knowledge may change, or a family pattern may remain unexplained. A genetic counselor can help people manage that uncertainty, identify whether follow-up or periodic reinterpretation is relevant, and avoid making decisions unsupported by the evidence.
Conclusion: counseling turns inherited risk into informed action
Genetic counseling transforms understanding of inherited risk by combining family history, genetic science, and individual priorities. It clarifies that risk is not certainty, explains what testing can and cannot show, interprets positive, negative, and uncertain results, and connects findings with care and family communication. With inherited factors implicated in a meaningful share of some conditions—and family history relevant to many more—this process can help people ask better questions and make choices grounded in evidence rather than fear or false reassurance.
If you are concerned about a pattern of illness in your family, write down relatives’ diagnoses and ages at diagnosis, then discuss the history with a health-care professional or genetic counselor. Ask what a test could change, what an inconclusive result might mean, and how findings could affect relatives. For further reading, consult the NSGC, CDC, National Cancer Institute, MedlinePlus, and FDA resources on genetic counseling, family history, and genetic testing.
Sources: National Society of Genetic Counselors, “About Genetic Counselors,” https://www.nsgc.org/About/About-Genetic-Counselors; Centers for Disease Control and Prevention, “Family Health History,” https://www.cdc.gov/family-health-history/about/index.html; National Cancer Institute, “The Genetics of Cancer,” https://www.cancer.gov/about-cancer/causes-prevention/genetics; U.S. National Library of Medicine, MedlinePlus, “What is genetic testing?” https://medlineplus.gov/genetics/understanding/testing/genetictesting/; Richards et al., American College of Medical Genetics and Genomics, “Standards and guidelines for the interpretation of sequence variants,” https://pmc.ncbi.nlm.nih.gov/articles/PMC4544753/; U.S. Food and Drug Administration, “Direct-to-Consumer Tests,” https://www.fda.gov/medical-devices/in-vitro-diagnostics/direct-consumer-tests; National Human Genome Research Institute, “Genetic Discrimination,” https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination